Abstract

BackgroundSclerosing mesenteritis is a non-neoplastic inflammatory disease that occurs in the bowel mesentery. Distinguishing sclerosing mesenteritis from neoplasms may be difficult because of the clinical and radiographic similarities between the two disease entities.Case presentationWe report a case of sclerosing mesenteritis mimicking peritoneal metastases of colorectal carcinoma. A 73-year-old man with stage II descending colon adenocarcinoma with poor prognostic features was found to have developed left lower abdominal quadrant masses on computed tomography (CT) 9 months after undergoing radical surgery. These masses were diagnosed as peritoneal metastases because they grew in size and displayed fluorodeoxyglucose (FDG) uptake 3 months later; thus, a laparotomy was performed. The masses, which were localized in the jejunal mesentery, were excised completely via segmental jejunal resection. Histopathological analysis confirmed that the masses were sclerosing mesenteritis. The patient showed no signs of sclerosing mesenteritis or colorectal carcinoma recurrence during follow-up.ConclusionsIn patients suspected of having localized peritoneal metastasis from malignancies, any masses must be sampled by surgical excisional biopsy and subsequently examined to rule out alternative diagnoses, such as sclerosing mesenteritis.

Highlights

  • Sclerosing mesenteritis is a non-neoplastic inflammatory disease that occurs in the bowel mesentery

  • In patients suspected of having localized peritoneal metastasis from malignancies, any masses must be sampled by surgical excisional biopsy and subsequently examined to rule out alternative diagnoses, such as sclerosing mesenteritis

  • We report the case of a patient who underwent surgery for presumed metachronous localized peritoneal metastases from descending colon cancer and was diagnosed with sclerosing mesenteritis and avoided receiving unnecessary chemotherapy

Read more

Summary

Conclusions

Sclerosing mesenteritis can mimic peritoneal metastasis from malignancies, and it is necessary to excise and examine a mesenteric nodule developing in patients with a history of malignancy to distinguish recurrence and differential diagnosis such as sclerosing mesenteritis. Abbreviations CA19-9: Carbohydrate antigen; CEA: Carcinoembryonic antigen; CT: Computed tomography; FDG: Fluorodeoxyglucose; MRI: Magnetic resonance imaging; PET scan: Positron emission tomography

Background
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call